Green Valley Drugs Recalls Sodium Bicarbonate and Lidocaine Injection
Green Valley Drugs is recalling 335 vials of Sodium Bicarbonate and Lidocaine Injection due to a lack of assurance of sterility in its compounding and quality control processes.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance for an injectable drug, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 335 vials of Sodium Bicarbonate and Lidocaine Injection, all strengths and presentations. The recall was initiated because the compounding pharmacy lacked assurance of sterility for all sterile products it compounded, repackaged, and distributed, raising concerns about its quality control processes.
The affected product is distributed nationwide. Specific lot numbers and expiration dates are listed in the recall documentation, including lots expiring between April and June 2013.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Sodium Bicarbonate and Lidocaine Injection, all strengths and all presentations including Sod-Bicarb-Lido-0.27-2.73-3 syr, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 335
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: 20130226-GV4
- Exp 5/26/2013
- 13031150GV3
- Exp 6/11/2013
- 13031240GV4
- Exp 6/12/2013
- 13012325GV5
- Exp 4/23/2013
- 13021820GV3
- Exp 5/18/2013
- 13011520
- Exp 4/15/2013
- 13012425GV1
- Exp 4/24/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereKey Pharmacy Recalls Sodium Bicarbonate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereWells Pharmacy Recalls Sodium Bicarbonate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- CriticalGreen Valley Drugs Recalls Cyanocobalamin Injection Due to Sterility Failure
FDA (Drugs) · 2013-05-22
- HighSodium Bicarbonate 8.4% Injectable Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2022-06-01
- SeverePremier Pharmacy Labs Recalls Sodium Bicarbonate Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SevereSodium Bicarbonate Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2013-09-18